GSK | Law Firm Newswire

Waxahachie, TX (Law Firm Newswire) November 14, 2014 – Recently, U.S. courts have issued a series of decisions regarding venues in several of the ongoing lawsuits addressing birth defects caused by Paxil, an antidepressant drug made by GlaxoSmithKline (GSK). GSK recently lost its bid to have a group of cases heard in federal court rather than in Pennsylvania state court. In a different lawsuit, GSK won its appeal to have a case heard in Ohio rather than in Pennsylvania. In that case, the plaintiff’s attorneys now claim that GSK will unfairly benefit, as ex-employees of GSK will be less likely […]


Continue reading full article »